Pre-operative enhanced magnetic resonance imaging combined with clinical features predict early recurrence of hepatocellular carcinoma after radical resection

doi:10.4251/wjgo.v16.i4.1192

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1060)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

HTML

596

Figures (1-2)

Tables (1-5)

Sum=762

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

205

Sum=271

Apr 15, 2024 (publication date) through Jul 4, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1192-1203
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1192

Table 1 Clinical data of hepatocellular carcinoma patients with early or non-early recurrence after resection, n (%)

Factors		Early recurrence, n = 73 (%)	Non-early recurrence, n = 88 (%)	χ²/t	P value
Age (yr)	-	53.47 ± 11.07	59.88 ± 9.76	-3.902	0.000^b
Serum albumin	-	40.43 ± 4.21	40.05 ± 5.27	0.501	0.617
Total bilirubin	-	17.24 ± 10.52	18.62 ± 8.84	-0.903	0.368
Gender	Male	62 (84.9)	80 (90.9)	1.370	0.242
	Female	11 (15.1)	8 (9.1)	-	-
Age (group)	> 50	43 (58.9)	76 (86.4)	17.679	0.000^b
	≤ 50	30 (41.1)	12 (13.6)	-	-
Hepatitis B	Positive	72 (98.6)	81 (92.0)	Fisher	0.073
	Negative	1 (1.4)	7 (8.0)	-	-
Cirrhosis	Present	40 (54.8)	50 (56.8)	0.066	0.797
	Absent	33 (45.2)	38 (43.8)	-	-
HBV-DNA	Negative	12 (16.4)	19 (21.6)	0.681	0.409
	Positive	61 (83.6)	69 (78.4)	-	-
AFP	> 100	44 (60.3)	30 (34.1)	11.013	0.001^b
	≤ 100	29 (39.7)	58 (65.9)	-	-
Child-Pugh score	A	68 (93.2)	74 (84.1)	3.146	0.076
	B	5 (6.8)	14 (15.9)	-	-
Portal hypertension	Present	23 (31.5)	27 (30.7)	0.013	0.910
	Absent	50 (68.5)	61 (69.3)	-	-
Operation mode	Local excision	21 (28.8)	34 (38.6)	2.261	0.133
	Anatomical excision	52 (71.2)	54 (61.4)	-	-
Postoperative HAIC	Present	13 (17.8)	11 (12.5)	0.886	0.346
	Absent	60 (82.2)	77 (87.5)	-	-
BCLC stage	0	3 (4.1)	9 (10.2)	26.919	0.000^b
	A	29 (39.7)	62 (70.5)	-	-
	B	15 (20.5)	11 (12.5)	-	-
	C	26 (35.6)	6 (6.8)	-	-
CNLC stage	I	31 (42.5)	72 (81.8)	29.060	0.000^b
	II	16 (21.9)	10 (11.4)	-	-
	III	26 (35.6)	6 (6.8)	-	-
Degree of pathological differentiation	Low	10 (13.7)	15 (17.0)	3.397	0.183
	Middle	62 (84.9)	67 (76.1)	-	-
	High	1 (1.4)	6 (6.8)	-	-
Pathological satellite focus	Present	15 (20.5)	6 (6.8)	6.631	0.010^b
	Absent	58 (79.5)	82 (93.2)	-	-
MVI	Present	39 (53.4)	17 (19.3)	20.461	0.000^b
	Absent	33 (46.6)	71 (80.7)

^bP < 0.01.

HBV: Hepatitis B virus; AFP: Alpha-fetoprotein; HAIC: Hepatic artery infusion chemotherapy; BCLC: Barcelona Clinic Liver Cancer; CNLC: China liver cancer; MVI: Microvascular invasion.

Citation: Chen JP, Yang RH, Zhang TH, Liao LA, Guan YT, Dai HY. Pre-operative enhanced magnetic resonance imaging combined with clinical features predict early recurrence of hepatocellular carcinoma after radical resection. World J Gastrointest Oncol 2024; 16(4): 1192-1203
URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1192.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1192